| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | SCHEDULE 13G |
| 09 Nov 2026 |
Form 4: Burke William W, Director
Sold 5,000 shares ($135K) |
| 06 Nov 2026 |
Form 4: Kiewiet Stephen A., Chief Operating Officer
Received 6,438 shares as a grant or award |
| 06 Nov 2026 |
Form 3: Kiewiet Stephen A., Chief Operating Officer
No securities owned |
| 05 Nov 2026 |
Form 4: King Laura G., Director
Sold 4,800 shares ($120K) |
| 03 Nov 2026 | 144 |
| 03 Nov 2026 | FORM 10-Q/A |
| 03 Nov 2026 | FORM 10-Q/A |
| 02 Nov 2026 | 10-Q |
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition
MINNEAPOLIS, MN, November 2, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results ... |
| 20 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 |
Form 4: Dodd Sheri Louise, Director
Sold 10,978 shares ($323K) |
| 10 Aug 2026 | 144 |
| 10 Aug 2026 | 10-Q |
| 10 Aug 2026 |
8-K: Results of Operations and Financial Condition
MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results... |
| 13 Jul 2026 |
8-K: Regulation FD Disclosure; Other Events
Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients |
| 01 Jun 2026 | FORM SD |
Loading...